{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:08:22Z","timestamp":1772762902911,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2020,4,2]]},"DOI":"10.1080\/03007995.2020.1725744","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T09:13:38Z","timestamp":1580980418000},"page":"661-666","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["The mirogabalin ALDAY phase 3 program in pain associated with fibromyalgia: the lessons learned"],"prefix":"10.1080","volume":"36","author":[{"given":"Domenico","family":"Merante","sequence":"first","affiliation":[{"name":"Global Clinical Development","place":["Amersham, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,2,23]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1044"},{"issue":"11","key":"e_1_3_3_3_1","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1093\/pm\/pnw342","article-title":"Efficacy of mirogabalin (DS-5565) on patient-reported pain and sleep interference in patients with diabetic neuropathic pain: secondary outcomes of a phase 2 proof-of-concept study","volume":"18","author":"Merante D","unstructured":"Merante D, Rosenstock J, Sharma U, Feins K, Hsu C, and Vinik A; on behalf of the DS-5565-A-U201\u2009US Phase II Study Investigators. Efficacy of mirogabalin (DS-5565) on patient-reported pain and sleep interference in patients with diabetic neuropathic pain: secondary outcomes of a phase 2 proof-of-concept study. Pain Med. 18(11):2198\u20132207.","journal-title":". Pain Med"},{"key":"e_1_3_3_4_1","unstructured":"Daiichi Sankyo announces marketing approval in Japan of \u201cTarlige\u00ae tablets\u201d for pain treatment. 8 January 2019 [cited 2019 Dec 31]. Available from: https:\/\/www.daiichisankyo.com\/media_investors\/media_relations\/press_releases\/detail\/006959.html."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/pmt-2018-0024"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt053"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3266"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20531"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11272"},{"key":"e_1_3_3_10_1","unstructured":"Daiichi S. Press release of ALDAY program results on June 30 2017. 2017 [cited 2019 Dec 31]. Available from: https:\/\/www.daiichisankyo.com\/media_investors\/media_relations\/press_releases\/detail\/006653.html."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1629757"},{"key":"e_1_3_3_12_1","first-page":"1","article-title":"Current Med","volume":"9","author":"Food and Drug Administration","year":"2019","unstructured":"Food and Drug Administration. FDA draft guidance of pain drug development. Citation n. 29 from Current Med. Res Opin. 2019;9:1\u201311.","journal-title":"Res Opin"},{"issue":"4","key":"e_1_3_3_13_1","first-page":"272","article-title":"Clinical trial outcome in neuropathic pain: relationship to study characteristics","volume":"70","author":"Katz J","year":"2007","unstructured":"Katz J, Finnerup NB, Dworkin RH. Clinical trial outcome in neuropathic pain: relationship to study characteristics. Neurology. 2007;70(4):272\u2013263.","journal-title":"Neurology"},{"key":"e_1_3_3_14_1","first-page":"CD012188","article-title":"Gabapentin for fibromyalgia pain in adults","volume":"1","author":"Cooper TE","year":"2017","unstructured":"Cooper TE, Derry S, Wiffen PJ et\u00a0al. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst Rev. 2017;1:CD012188.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200868150-00009"},{"issue":"5","key":"e_1_3_3_16_1","first-page":"224","article-title":"Efficacy of duloxetine efficacy in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials","volume":"11","author":"Arnold LM","year":"2009","unstructured":"Arnold LM, Clauw D, Wohlreich MM, et\u00a0al. Efficacy of duloxetine efficacy in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials. J Clin Psychiatry. 2009;11(5):224\u2013237.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/jpr.s7883"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.589836"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz077"},{"key":"e_1_3_3_20_1","unstructured":"Merante D Patel S. Impact of the placebo response in drug clinical setting for the treatment of fibromyalgia. Poster presented at the British Pain Society Annual Scientific Meeting 2017; 2017 May 4; Birmingham United Kingdom."},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00349-9"},{"key":"e_1_3_3_22_1","unstructured":"Merante D Patel S. Average daily pain score or average daily worst pain score as primary endpoint in fibromyalgia phase 3 clinical studies with alpha delta 2 ligands? Poster PSN331 presented at IASP 2018; 2018 Sep 16; Boston MA."},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25565"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.08.003"},{"key":"e_1_3_3_25_1","unstructured":"Merante D Cole L. Outside-in: why putting patients at the heart of drug development matters. Paper published in Applied Clinical Trials Online on 26 October 2018. [cited 2019 Dec 31]. Available from: http:\/\/www.appliedclinicaltrialsonline.com\/outside-why-putting-patients-heart-drug-development-matters."},{"key":"e_1_3_3_26_1","unstructured":"ClinicalTrials.gov Identifier: NCT02146430. Treatment of pain associated with fibromyalgia [Internet]. [cited 2020 Jan 17]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02146430."}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2020.1725744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T13:48:30Z","timestamp":1770385710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2020.1725744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,23]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,2]]}},"alternative-id":["10.1080\/03007995.2020.1725744"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2020.1725744","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}